Category: Immunoassay

Immunoassay

Revvity, Inc. has launched the IDS i20, a fully automated, high-throughput platform for ChLIA, enabling labs to consolidate specialty tests.

EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG), is validated for DBS samples, to enhance measles diagnosis and immunity assessment.

Revvity received FDA 510(k) clearance for EUROIMMUN’s automated immunoassay for direct quantitative measurement of free testosterone.

Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.

Personalis, Inc. has partnered with Tempus to commercialize NeXT Personal, an ultra-sensitive, whole genome-based liquid biopsy assay.

Researchers are developing a rapid, non-invasive saliva test to detect tetanus immunity in children across low-middle income countries.